HBIO — Harvard Bioscience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Annual balance sheet for Harvard Bioscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	8.32	7.82	4.51	4.28	4.11
Net Total Accounts Receivable
Net Total Receivables	21.1	26.2	20.2	20	14.9
Total Inventory
Total Other Current Assets
Total Current Assets	51.7	61.6	51.1	49	45.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.7	10.3	9.18	8.75	11.2
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	156	162	145	137	127
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	21.1	25.3	23.2	26.5	55
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	79.6	78.9	73.1	64.3	63.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	76.7	83.4	72.2	73.1	63.3
Total Liabilities & Shareholders' Equity	156	162	145	137	127
Total Common Shares Outstanding